Objectives: This study investigated the benefits of, and barriers to user involvement in medical device technology development and evaluation. Methods: A structured review of published literature in peer-reviewed journals. Results: This review revealed that the main benefits of user involvement were an increased access to user needs, experiences and ideas; improvements in medical device designs and user interfaces; and an increase in the functionality, usability and quality of the devices. On the other hand, resource issues, particularly those of time and money were found the key impediments to involving users in the development and evaluation of medical device technologies. This study has categorised both the benefits and barriers to user involvement also. Conclusions: The involvement of users in MDTD&E requires resources, which are limited; however, it is essential from both users and manufacturers perspectives.
INTRODUCTION
Users of medical devices are involved in the development and evaluation of medical device technology due to their potentially vital role in the innovation, development, assessment, implementation and dissemination of the technology (1;3). Engagement with the users is also now required under medical device regulations (66) . However, (68) . In addition, users play an important role in the implementation of new medical device technologies, and their integration in existing structures, such as the involvement of clinicians and medical laboratory staff in the implementation and integration of patient based record systems in relation to the wide range of tests carried out in microbiology and pathology laboratories (54).
Regulatory Controls. Another advantage of involving users in MDTD&E is
the fulfilment of regulatory requirements, which require user participation and user focused development of medical device technologies (14;66). This is not just in terms of a ritual fulfilment of basic statutory requirements, but in practice in ensuring a more effective set of ways in which those requirements can be innovatively met.
Thus, involvement of users in MDTD&E is rewarding (8). It helps in embedding user perspectives in medical device technologies to the benefit of users (51) as well as bringing benefits to the manufacturer through the development of successful products, thereby attract higher sales and profits (39;40;59). On the contrary, non-involvement of users in MDTD&E may lead to the development of user [131] [132] [133] [134] [135] [136] [137] technology development cycle. Therefore, the culture within the manufacturing organisation particularly the attitudes of product development personnel may affect the involvement of users in MDTD&E because they may regard the idea of user involvement overall as less valuable and unnecessary (37); thus, they may therefore oppose it (63) . In this case, medical device technology manufacturers can be argued to need a cultural shift in attitudes (37) so that there is encouragement of user participation in the technology development and evaluation process (58) . On the other hand, whilst it is possible that manufacturers are more than willing to employ user input into MDTD&E; however, the processes required for incorporating such user perspectives within in the technology development cycle are limited or ineffective (19). For example, methodologies that are reliable, robust, fast and cheap need to be identified developed and/or modified in order to facilitate the user involvement.
Regulatory Controls. Other factors that can limit involvement of users in MDTD&E may include stringent regulatory controls and ethical approvals concerning the involvement of users. These may inhibit or prevent the easy incorporation of users in various stages of device development.
LIMITATIONS AND FUTURE RESEARCH Limitations
The findings of this literature review are indicative rather than comprehensive since it is mainly based on social sciences literature. The inclusion of broader literature in the engineering and medical fields might have been useful, although the authors have found that there is generally limited published data in these fields on the issues they 
